My research and health policy interests are the development of innovative therapies and diagnostics for unmet medical needs and cross-sectoral collaboration. I trained in Biology and Pharmacy at the University of Düsseldorf, Germany: PhD in Biology (2003); graduation in Pharmacy (2004). I worked several years as the Deputy Head of the Pharmaceutical Medicines Unit at the Swiss Tropical and Public Health Institute, Basel. My passion for health system strengthening and product development partnerships stems from frequent work assignments in Sub-Saharan Africa. Subsequently I moved to the World Health Organization (WHO) where I coordinated the Better Medicines for Children project and the Paediatric medicines Regulators Network (PmRN). In 2011 I joined Novartis Vaccines and Diagnostics (Siena, Italy) as a Senior Clinical Research Scientist where I led clinical development programmes in pandemic and paediatric vaccines. In my current position as a Health Policy Analyst at the OECD (Science and Technology Policy Division) I support the Working Party on Biotechnology, Nanotechnology and Converging Technologies (BNCT); foci of my work are: the development and use of novel technologies in biomedical research and clinical application; advancing regulatory science; and, ethical, legal and social implications of emerging technologies.